[Congressional Bills 115th Congress]
[From the U.S. Government Publishing Office]
[H.R. 5327 Engrossed in House (EH)]
<DOC>
115th CONGRESS
2d Session
H. R. 5327
_______________________________________________________________________
AN ACT
To amend title V of the Public Health Service Act to establish a grant
program to create comprehensive opioid recovery centers, and for other
purposes.
Be it enacted by the Senate and House of Representatives of the
United States of America in Congress assembled,
SECTION 1. SHORT TITLE.
This Act may be cited as the ``Comprehensive Opioid Recovery
Centers Act of 2018''.
SEC. 2. COMPREHENSIVE OPIOID RECOVERY CENTERS.
(a) In General.--Part D of title V of the Public Health Service Act
is amended by adding at the end the following new section:
``SEC. 550. COMPREHENSIVE OPIOID RECOVERY CENTERS.
``(a) In General.--The Secretary shall award grants on a
competitive basis to eligible entities to establish or operate a
comprehensive opioid recovery center (referred to in this section as a
`Center').
``(b) Grant Period.--
``(1) In general.--A grant awarded under subsection (a)
shall be for a period not less than 3 years and not more than 5
years.
``(2) Renewal.--A grant awarded under subsection (a) may be
renewed, on a competitive basis, for additional periods of
time, as determined by the Secretary. In determining whether to
renew a grant under this paragraph, the Secretary shall
consider the data submitted under subsection (h).
``(c) Minimum Number of Centers.--The Secretary shall allocate the
amounts made available under subsection (i) in such amounts that not
fewer than 10 Centers will be established across the United States.
``(d) Application.--In order to be eligible for a grant under
subsection (a), an entity shall submit an application to the Secretary
at such time and in such manner as the Secretary may require. Such
application shall include--
``(1) evidence that such entity carries out, or is capable
of coordinating with other entities to carry out, the
activities described in subsection (g); and
``(2) such other information as the Secretary may require.
``(e) Priority.--In awarding grants under subsection (a), the
Secretary shall give priority to eligible entities located in a State
or Indian country (as defined in section 1151 of title 18, United
States Code)--
``(1) with a high per capita drug overdose mortality rate,
as determined by the Director of the Centers for Disease
Control and Prevention; or
``(2) based on any other criteria or need, as determined by
the Secretary.
``(f) Use of Grant Funds.--An eligible entity awarded a grant under
subsection (a) shall use the grant funds to establish or operate a
Center to carry out the activities described in subsection (g).
``(g) Center Activities and Services.--Each Center shall, at a
minimum, carry out the activities described in this subsection. In the
case of a Center that determines that a service described in paragraph
(2) cannot reasonably be carried out by the Center, such Center shall
contract with such other entities as may be necessary to ensure that
patients have access to the full range of services described in such
paragraph.
``(1) Community outreach.--Each Center shall carry out the
following outreach activities:
``(A) Train and supervise outreach staff to work
with schools, workplaces, faith-based organizations,
State and local health departments, law enforcement,
and first responders to ensure that such institutions
are aware of the services of the Center.
``(B) Disseminate and make available online
evidence-based resources that educate professionals and
the public on opioid use disorder and other substance
use disorders.
``(2) Treatment and recovery services.--Each Center shall
provide the following treatment and recovery services:
``(A) Ensure that intake evaluations meet the
clinical needs of patients.
``(B) Periodically conduct patient assessments to
ensure continued and meaningful recovery, as defined by
the Assistant Secretary for Mental Health and Substance
Use.
``(C) Provide the full continuum of treatment
services, including--
``(i) all drugs approved under section 505
of the Federal Food, Drug, and Cosmetic Act and
all biological products licensed under section
351 of this Act, including methadone, to treat
substance use disorders, including opioid use
disorder and alcohol use disorder;
``(ii) withdrawal management, which shall
include medically supervised detoxification
that includes patient evaluation,
stabilization, and readiness for and entry into
treatment;
``(iii) counseling and case management,
including counseling and recovery services for
any possible co-occurring mental illness;
``(iv) residential rehabilitation;
``(v) recovery housing;
``(vi) community-based and peer recovery
support services;
``(vii) job training and placement
assistance to support reintegration into the
workforce; and
``(viii) other best practices, as
determined by the Secretary.
``(D) Administer an onsite pharmacy and provide
toxicology services.
``(E) Establish and operate a secure and
confidential electronic health information system.
``(F) Offer family support services such as child
care, family counseling, and parenting interventions to
help stabilize families impacted by substance use
disorder.
``(h) Data Reporting and Program Oversight.--With respect to a
grant awarded under subsection (a) to an eligible entity for a Center,
not later than 90 days after the end of the first year of the grant
period, and annually thereafter for the duration of the grant period
(including the duration of any renewal period for such grant), the
entity shall submit data, as appropriate, to the Secretary regarding--
``(1) the programs and activities funded by the grant;
``(2) health outcomes of individuals with a substance use
disorder who received services from the Center;
``(3) the effectiveness of interventions designed, tested,
and evaluated by the Center; and
``(4) any other information that the Secretary may require
for the purpose of--
``(A) evaluating the effectiveness of the Center;
and
``(B) ensuring that the Center is complying with
all the requirements of the grant, including providing
the full continuum of services described in subsection
(g)(2)(C) and providing drugs and devices for overdose
reversal under such subsection.
``(i) Authorization of Appropriations.--There is authorized to be
appropriated $10,000,000 for each of fiscal years 2019 through 2023 for
purposes of carrying out this section.''.
(b) Reports to Congress.--
(1) Preliminary report.--Not later than 3 years after the
date of the enactment of this Act, the Secretary of Health and
Human Services shall submit to Congress a preliminary report
that analyzes data submitted under section 550(h) of the Public
Health Service Act, as added by subsection (a).
(2) Final report.--Not later than 1 year after submitting
the preliminary report required under paragraph (1), the
Secretary of Health and Human Services shall submit to Congress
a final report that includes--
(A) an evaluation of the effectiveness of
comprehensive opioid recovery centers established or
operated pursuant to section 550 of the Public Health
Service Act, as added by subsection (a);
(B) recommendations on whether the grant program
established under such section 550 should be
reauthorized and expanded; and
(C) standards and best practices for the treatment
of substance use disorders, as identified through such
grant program.
Passed the House of Representatives June 12, 2018.
Attest:
Clerk.
115th CONGRESS
2d Session
H. R. 5327
_______________________________________________________________________
AN ACT
To amend title V of the Public Health Service Act to establish a grant
program to create comprehensive opioid recovery centers, and for other
purposes.